Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial

BACKGROUND: Dysferlinopathies are autosomal recessive disorders caused by mutations in the dysferlin (DYSF) gene encoding the dysferlin protein. DYSF mutations lead to a wide range of muscular phenotypes, with the most prominent being Miyoshi myopathy (MM) and limb girdle muscular dystrophy type 2B...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Walter, Maggie C, Reilich, Peter, Thiele, Simone, Schessl, Joachim, Schreiber, Herbert, Reiners, Karlheinz, Kress, Wolfram, Müller-Reible, Clemens, Vorgerd, Matthias, Urban, Peter, Schrank, Bertold, Deschauer, Marcus, Schlotter-Weigel, Beate, Kohnen, Ralf, Lochmüller, Hanns
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2013
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3617000/
https://ncbi.nlm.nih.gov/pubmed/23406536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-8-26
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk